Business · Corrected
AstraZeneca Stomach Cancer Drug Extends Survival in Late-Stage Trial but Misses Second Goal
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
An experimental AstraZeneca drug extended survival for patients with advanced…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
2 sources behind this story.
Updates
Correction, : Correction: The side-effect percentages refer to grade 3 or higher treatment-related adverse events, not the separate category of serious adverse events.